New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy. (2020)

First Author: Maltês S
Attributed to:  Discovering the causes of mutation-negative hypertrophic cardiomyopathy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.repc.2019.03.008

PubMed Identifier: 32245685

Publication URI: http://europepmc.org/abstract/MED/32245685

Type: Journal Article/Review

Volume: 39

Parent Publication: Revista portuguesa de cardiologia

Issue: 2

ISSN: 2174-2049